Carolan CG, Dillon GP, Khan D, Ryder SA, Gaynor JM, Reidy S, Marquez JF, Jones M, Holland V, Gilmer JF (2010) <br />Isosorbide-2-benzyl carbamate-5-salicylate, a peripheral anionic site binding subnanomolar selective butyrylcholinesterase inhibitor<br /><i>Journal of Medicinal Chemistry</i> <b>53</b>: 1190<br /><br />Dillon GP, Gaynor JM, Khan D, Carolan CG, Ryder SA, Marquez JF, Reidy S, Gilmer JF (2010) <br />Isosorbide-based cholinesterase inhibitors; replacement of 5-ester groups leading to increased stability<br /><i>Bioorganic & Medicinal Chemistry</i> <b>18</b>: 1045<br /><br />Jones M, Inkielewicz I, Medina C, Santos-Martinez MJ, Radomski A, Radomski MW, Lally MN, Moriarty LM, Gaynor J, Carolan CG, Khan D, O'Byrne P, Harmon S, Holland V, Clancy JM, Gilmer JF (2009) <br />Isosorbide-based aspirin prodrugs: integration of nitric oxide releasing groups<br /><i>Journal of Medicinal Chemistry</i> <b>52</b>: 6588<br /><br />Carolan CG, Gaynor JM, Dillon GP, Khan D, Ryder SA, Reidy S, Gilmer JF (2008) <br />Novel isosorbide di-ester compounds as inhibitors of acetylcholinesterase<br /><i>Chemico-Biological Interactions</i> <b>175</b>: 293<br /><br />Khan D, Gilmer JF, Carolan CG, Gaynor JM, Ryder SA (2008) <br />Pharmacological effects of a novel isosorbide-based butyrylcholinesterase inhibitor<br /><i>Chemico-Biological Interactions</i> <b>175</b>: 231<br /><br />Moriarty LM, Lally MN, Carolan CG, Jones M, Clancy JM, Gilmer JF (2008) <br />Discovery of a true aspirin prodrug<br /><i>Journal of Medicinal Chemistry</i> <b>51</b>: 7991<br /><br />